Sclerosis News and Research RSS Feed - Sclerosis News and Research

MS study uses fNIRS to examine brain activation during working memory task

MS study uses fNIRS to examine brain activation during working memory task

Using functional near infrared spectroscopy (fNIRS), Kessler Foundation researchers have shown differential brain activation patterns between people with multiple sclerosis (MS) and healthy controls. [More]
Researchers find method to expand blood stem cells used to treat cancer patients

Researchers find method to expand blood stem cells used to treat cancer patients

A team of scientists from the University of Colorado School of Medicine has reported the breakthrough discovery of a process to expand production of stem cells used to treat cancer patients. [More]
Report: Global Multiple Sclerosis Drugs market to grow at 5.56% CAGR over 2013-2018

Report: Global Multiple Sclerosis Drugs market to grow at 5.56% CAGR over 2013-2018

Research and Markets has announced the addition of the "Global Multiple Sclerosis Drugs Market 2014-2018" report to their offering. [More]
FDA accepts Mylan's ANDA filing for generic Copaxone 40 mg/mL

FDA accepts Mylan's ANDA filing for generic Copaxone 40 mg/mL

Mylan Inc. today announced that its abbreviated new drug application (ANDA) for a three times per week Glatiramer Acetate Injection 40 mg/mL has been accepted for filing by the U.S. Food and Drug Administration. [More]
New MS treatment found safe, tolerable in phase I clinical trials

New MS treatment found safe, tolerable in phase I clinical trials

A new treatment under investigation for multiple sclerosis (MS) is safe and tolerable in phase I clinical trials, according to a study published August 27, 2014, in Neurology Neuroimmunology & Neuroinflammation, a new online-only, freely accessible, specialty medical journal. [More]
Balance board accessory can help people with MS reduce risk of accidental falls

Balance board accessory can help people with MS reduce risk of accidental falls

A balance board accessory for a popular video game console can help people with multiple sclerosis (MS) reduce their risk of accidental falls, according to new research published online in the journal Radiology. [More]
Researchers find roving detection system for treating cancer, Parkinson's disease and ALS

Researchers find roving detection system for treating cancer, Parkinson's disease and ALS

Duke University researchers have found a "roving detection system" on the surface of cells that may point to new ways of treating diseases like cancer, Parkinson's disease and amyotrophic lateral sclerosis (ALS). [More]
Research to understand how medical marijuana laws may influence overdose deaths

Research to understand how medical marijuana laws may influence overdose deaths

In states where it is legal to use medical marijuana to manage chronic pain and other conditions, the annual number of deaths from prescription drug overdose is 25 percent lower than in states where medical marijuana remains illegal, new research suggests. [More]
Study sheds new light on sleep drunkenness disorder

Study sheds new light on sleep drunkenness disorder

A study is shining new light on a sleep disorder called "sleep drunkenness". The disorder may be as prevalent as affecting one in every seven people. The research is published in the August 26, 2014, print issue of Neurology, the medical journal of the American Academy of Neurology. [More]
Persons with MS may be able to improve self-awareness via task-oriented cognitive rehabilitation

Persons with MS may be able to improve self-awareness via task-oriented cognitive rehabilitation

A new study of self-awareness by Kessler Foundation researchers shows that persons with multiple sclerosis (MS) may be able to improve their self-awareness through task-oriented cognitive rehabilitation. [More]
Study finds a host of new clues on gene-environment interactions in Crohn's disease

Study finds a host of new clues on gene-environment interactions in Crohn's disease

A new study finds a wide range of epigenetic changes-alterations in DNA across the genome that may be related to key environmental exposures-in children with Crohn's disease (CD), reports Inflammatory Bowel Diseases, official journal of the Crohn's & Colitis Foundation of America. [More]
New mouse model to open door to research on epilepsy, Alzheimer's

New mouse model to open door to research on epilepsy, Alzheimer's

University of Utah scientists have developed a genetically engineered line of mice that is expected to open the door to new research on epilepsy, Alzheimer's and other diseases. [More]
Study suggests that colds may temporarily increase stroke risk in kids

Study suggests that colds may temporarily increase stroke risk in kids

A new study suggests that colds and other minor infections may temporarily increase stroke risk in children. The study is published in the August 20, 2014, online issue of Neurology®, the medical journal of the American Academy of Neurology. [More]
Glenmark announces discovery and initiation of IND enabling studies of innovative bispecific antibody

Glenmark announces discovery and initiation of IND enabling studies of innovative bispecific antibody

Glenmark Pharmaceuticals S.A. (GPSA), a wholly owned subsidiary of Glenmark Pharmaceuticals Limited India (GPL), announces the discovery and initiation of IND enabling studies of a novel clinical development candidate, GBR 1302, a HER2xCD3 bispecific antibody. [More]
Number of Vets being referred to private doctors is rising, VA secretary says

Number of Vets being referred to private doctors is rising, VA secretary says

Robert McDonald tells American Veterans national convention that his department is quickly moving to significantly increase the number of veterans referred to doctors outside the system. Also, the department announces that veterans with Lou Gehrig's Disease will be eligible for a government housing program. [More]
New therapeutic strategy to combat common genetic risk factor for ALS, FTD

New therapeutic strategy to combat common genetic risk factor for ALS, FTD

A team of researchers at Mayo Clinic and The Scripps Research Institute in Florida have developed a new therapeutic strategy to combat the most common genetic risk factor for the neurodegenerative disorders amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease) and frontotemporal dementia (FTD). [More]
Mortality predictors REVEALed for PAH in systemic sclerosis

Mortality predictors REVEALed for PAH in systemic sclerosis

Elderly men and patients with low baseline systolic blood pressure are among those at a particularly high risk of death from pulmonary arterial hypertension associated with systemic sclerosis, a US study has found. [More]
Synthetic Biologics hosts Investor Day to discuss irritable bowel syndrome program

Synthetic Biologics hosts Investor Day to discuss irritable bowel syndrome program

Synthetic Biologics, Inc. (NYSE MKT: SYN), a biotechnology company developing novel anti-infective biologic and drug candidates targeting specific pathogens that cause serious infections and diseases, announced today that it will host an Investor Day in New York to discuss the Company's irritable bowel syndrome (IBS) program, including its novel, oral product SYN-010, targeting constipation-predominant IBS (C-IBS). [More]
Study identifies novel gene that controls nerve conduction velocity linked with MS

Study identifies novel gene that controls nerve conduction velocity linked with MS

A new study published in The American Journal of Pathology identifies a novel gene that controls nerve conduction velocity. [More]
Study examines the influence of unexpected task constraint on voluntary task switching

Study examines the influence of unexpected task constraint on voluntary task switching

Kessler Foundation scientists have published results of cognitive research that show the negative effects that unexpected task constraint, following self-generated task choice, has on task-switching performance. [More]